[NIH SACGHS Webcasts]
[1 March 2004]
[2 March 2004]
[23 Oct 2003]
[22 Oct 2003]
[11 June 2003]
[12 June 2003]

National Institutes of Health

National Institutes of Health
Secretary's  Advisory Committee
 on Genetics, Health and Society



Secretary's Advisory Committee on Genetics, Health, and Society

Third Meeting
March 1-2, 2004
Washington, DC

D R A F T  A G E N D A

Monday, March 1, 2004


Opening Remarks

8:30 a.m. - 8:35 a.m.  Edward R.B. McCabe, M.D., Ph.D.

   SACGHS Chair


        • Report of the SACGHS Task Force
        • 8:35 a.m. 9:00 a.m. Review of Inter-Meeting Task Force Process, Results of Priority Setting Process, and a Proposed Framework for the Committee's Priority Setting Process
        • Emily Winn-Deen, Ph.D.
        • Chair, Intra-Meeting Task Force
        • 9:00 a.m. 10:30 a.m. Presentation of Background Information
        • Task Force Chair and/or Members
        • 10:30 a.m. 10:45 a.m. BREAK
        • Discussion of the Issues


        • 10:45 p.m. 12:30 p.m. Committee Discussion
        • 12:30 p.m. 1:30 p.m. Working Lunch
        • Public Comment Session

          1:30 p.m. 2:00 p.m.  Members of the Public

        • Coverage and Reimbursement for Genetic Services and Technologies
        • 2:00 p.m. 2:30 p.m. Medicare Coverage of Genetic Technologies and Coverage Decision-making Process
        • Sean Tunis, M.D., M.Sc.
           Chief Medical Officer
           Centers for Medicare & Medicaid Services
           Medicare Payment Rates and Rate-setting Process for Genetic Technologies
        • TBD
        • 2:30 p.m. 2:50 p.m. Coverage and Reimbursement Decision-making Process for Genetic Technologies by Private Health Plans
      • Michele Schoonmaker, Ph.D. (invited)
      • Congressional Research Service

        2:50 p.m. 3:05 p.m. BREAK
      • 3:05 p.m. 3:25 p.m.   Issues in the Reimbursement of Genetic Tests

        • Andrea Ferreira-Gonzalez, Ph.D.
          Associate Professor and Director, Molecular Diagnostics Lab
          Division of Molecular Diagnostics, Department of Pathology
          Virginia Commonwealth University
        • 3:25 p.m. 3:45 p.m.  Issues in the Reimbursement of Genetic Services

      • Marc Williams, M.D. (invited)
      • Gundersen Lutheran Medical Center

        3:45 p.m. 4:05 p.m. Economic Modeling: Coverage and Reimbursement of Genetic Services and Technologies and the Impact on the Health Care System
        • Ronald Bachman, M.D.
           Chief, Genetics Department
           Kaiser Permanente of Northern California
        • 4:05 p.m. 4:25 p.m. Cost-Effectiveness of Genetic Technologies
          David Veenstra, Pharm.D., Ph.D. (invited)\
          ProfessorDepartment of Clinical Pharmacy
          University of California, San Francisco School of Pharmacy
        • 4:25 p.m. - 5:30 p.m.                  Roundtable Discussion